STOCK TITAN

Liquidia to Report Second Quarter 2022 Financial Results on August 11, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Liquidia Corporation (NASDAQ: LQDA) will announce its second quarter 2022 financial results on August 11, 2022, with a conference call scheduled for 8:30 a.m. ET. The call will cover financial results and a corporate update. Interested parties can join by phone or access a webcast, which will be archived for 30 days. Liquidia focuses on developing treatments for pulmonary hypertension, including its inhalation powder YUTREPIA™. For more information, visit Liquidia's website.

Positive
  • Upcoming earnings announcement may provide insights into financial health.
  • Focus on pulmonary hypertension treatment could signal growth potential.
Negative
  • None.

MORRISVILLE, N.C., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its second quarter 2022 financial results on Thursday, August 11, 2022. The company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss financial results and provide a corporate update.

The live call may be accessed by dialing 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and entering the conference code: 8369322. A webcast of the call will be available and archived for 30 days on Liquidia’s website at https://liquidia.com/index.php/investors/events-and-presentations.

About Liquidia Corporation
Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology. The company operates through its two wholly owned subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia Technologies has developed YUTREPIA™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH). Liquidia PAH provides the commercialization for rare disease pharmaceutical products, such as generic Treprostinil Injection. For more information, please visit www.liquidia.com.

Contact Information for Media & Investors
Jason Adair
Senior Vice President, Corporate Development and Strategy
919.328.4400
jason.adair@liquidia.com 


FAQ

When will Liquidia report its second quarter 2022 earnings?

Liquidia will report its second quarter 2022 financial results on August 11, 2022.

What time is the Liquidia conference call scheduled for?

The Liquidia conference call is scheduled for 8:30 a.m. Eastern Time.

How can I access the Liquidia earnings call?

You can access the Liquidia earnings call by dialing 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and entering the conference code: 8369322.

What is the focus area of Liquidia Corporation?

Liquidia Corporation focuses on developing products for pulmonary hypertension using its PRINT® Technology.

Where can I find more information about Liquidia Corporation?

More information can be found on Liquidia's official website at www.liquidia.com.

Liquidia Corporation

NASDAQ:LQDA

LQDA Rankings

LQDA Latest News

LQDA Stock Data

912.38M
60.46M
19.49%
54.31%
12.25%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
MORRISVILLE